Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial

INTRODUCTION: The COVID-19 pandemic caused by the virus SARS-CoV has spread rapidly and caused damage worldwide. Data suggest a major overrepresentation of hypertension and diabetes among patients experiencing severe courses of COVID-19 including COVID-19-related deaths. Many of these patients recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Kliim-Hansen, Vivian, Gasbjerg, Lærke Smidt, Ellegaard, Anne-Marie, Lorentsson, Hans Johan Niklas, Lynggaard, Mads Bank, Hagemann, Christoffer Andersen, Legart, Christian, Mathiesen, David Siersbæk, Sivapalan, Pradeesh, Jensen, Jens-Ulrik Stæhr, Vilsbøll, Tina, Christensen, Mikkel Bring, Knop, Filip Krag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716414/
https://www.ncbi.nlm.nih.gov/pubmed/36450422
http://dx.doi.org/10.1136/bmjopen-2022-062895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716414/
https://www.ncbi.nlm.nih.gov/pubmed/36450422
http://dx.doi.org/10.1136/bmjopen-2022-062895

Ejemplares similares